Long-term assessment of T-cell populations in DiGeorge syndrome

Journal of Allergy and Clinical Immunology

Volumn 111, Issue 3, 2003, Pages 573-579

  Chinen, Javier ^a,b   Rosenblatt, Howard M ^a   Smith, E O'Brian ^a   Shearer, William T ^a   Noroski, Lenora M ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

22q11 deletion; DiGeorge syndrome; Immunodeficiency; T cell counts; Velocardiofacial syndrome

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; IMMUNOGLOBULIN; PHYTOHEMAGGLUTININ;

ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; CHILD; CHROMOSOME 22Q; CLINICAL ARTICLE; DIGEORGE SYNDROME; DISEASE COURSE; FEMALE; GENE DELETION; HUMAN; HUMORAL IMMUNITY; IMMUNOGLOBULIN DEFICIENCY; INFANT; LYMPHOCYTE COUNT; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MALE; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

EID: 0037339072     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2003.165     Document Type: Article

References (26)

1. Lischner HW, Huff DS. T-cell deficiency in DiGeorge syndrome. Birth Defects: Original Article Series 1975;11:16-21.
2. Conley ME, Notarangelo LD, Etzioni A. Diagnostic criteria for primary immunodeficiencies. Clin Immunol 1999;93:190-7.
3. Driscoll DA, Budarf ML, Emanuel BS. A genetic etiology for DiGeorge Syndrome: consistent deletions and microdeletions of 22q11. Am J Hum Genet 1992;50:924-33.
4. Lindsay EA, Vitelli F, Su H, Morishika M, Huynh T, Pramparo T, et al. Tbx1 haploinsufficiency in the DiGeorge syndrome region causes aortic arch defects in mice. Nature 2001;410:97-101.
5. Pierdominici M, Marziali M, Giovannetti A, Oliva A, Rosso R, Marino B, et al. T cell receptor repertoire and function in patients with DiGeorge syndrome and velocardiofacial syndrome. Clin Exp Immunol 2000;121:127-32.
6. Conley ME, Beckwith JB, Mancer JFK, Tenckoff L. The spectrum of the DiGeorge syndrome. J Pediatr 1979;94:883-90.
7. Markert ML, Boeck A, Hale LP, Kloster AL, McLaughlin TM, Batchvarova MN, et al. Transplantation of thymus in complete DiGeorge Syndrome. N Engl J Med 1999;341:1180-9.
8. Markert ML, Hummell DS, Rosenblatt HM, Schiff SE, Harville TO, Williams LW, et al. Complete DiGeorge syndrome: persistence of profound immunodeficiency. J Pediatr 1998;132:15-23.
9. Bastian J, Law S, Vogler L, Lawton A, Herrod H, Anderson S, et al. Prediction of persistent immunodeficiency in the DiGeorge anomaly. J Pediatr 1989;115:391-6.
10. Barrett DJ, Ammann AJ, Wara DW, Cowan MJ, Fisher TJ, Stiehm ER. Clinical and immunological spectrum of DiGeorge syndrome. J Clin Lab Immunol 1981;6:1-6.
11. Sullivan KE, McDonald-McGinn D, Driscoll DA, Emanuel BS, Zackai EH, Jawad AF. Longitudinal analysis of lymphocyte function and numbers in the first year of life in chromosome 22q11.2 deletion syndrome (DiGeorge Syndrome/velocardiofacial syndrome). Clin Diagn Lab Immunol 1999;6:906-11.
12. Jawad FA, McDonald-McGinn DM, Zackai E, Sullivan KE. Immunologic features of chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). J Pediatr 2001;139:715-23.
13. Berend SA, Spikes AS, Kashork CD, Wu JM, Daw SC, Scambler PJ, et al. Dual-Probe fluorescence in situ hybridization assay for detecting deletions associated with VCFS/DiGeorge Syndrome 1 and DiGeorge Syndrome 11 loci. Am J Med Genet 2000;91:313-7.
14. Denny T, Yogev R, Gelman R, Skuza C, Oleske J, Chadwick E, et al. Lymphocyte subsets in healthy children during the first five years of life. JAMA 1992;267:1484-8.
15. US Census Bureau. The Hispanic population: Census 2000 brief. Washington: US Census Bureau; 2001. p. 7.
16. Kornfeld SJ, Zeffren B, Christodoulou CS, Day NK, Cawkwell G, Good RA. DiGeorge anomaly: a comparative study of the clinical and immunologic characteristics of patients positive and negative by fluorescence in situ hybridization. J Allergy Clin Immunol 2000;105:983-7.
17. Greig F, Paul E, DiMartino-Nardi J, Saenger P. Transient congenital hypoparathyroidism: resolution and recurrence in chromosome 22q11 deletion. J Pediatr 1996;128:563-7.
18. Centers for Disease Control and Prevention. 1994 revised classification system for children with human immunodeficiency virus infection in children less than 13 years. MMWR 1994;43:1-19.
19. Muller W, Peter HH, Kallfelz HC, Franz A, Rieger CHL. The DiGeorge sequence. II. Immunological findings in partial and complete forms of the disorder. Eur J Pediatr 1989;19:96-103.
20. Etzioni A, Pollack S. Hypogammaglobulinemia in DiGeorge sequence. Eur J Pediatr 1989;150:144-5.
21. Mayumi M, Kimata H, Suehiro Y, Hosoi S, Ito S, Kuge Y, et al. DiGeorge syndrome with hypogammaglobulinemia: a patient with excess suppressor T cell activity treated with fetal thymus transplantation. Eur J Pediatr 1989;148:512-22.
22. Schubert MS, Moss RB. Selective polysaccharide antibody deficiency in familial DiGeorge syndrome. Ann Allergy 1992:69:231-8.
23. Smith CA, Driscoll DA, Emanuel BS, McDonald-McGinn DM, Zackai EH, Sullivan KE. Increased prevalence of immunoglobulin A deficiency in patients with the chromosome 22q11.2 deletion syndrome. Clin Immunol Immunopathol 1998;86:141-6.
24. Junker AK, Driscoll DA. Humoral immunity in DiGeorge syndrome. J Pediatr 1995;127:231-7.
25. Ham Pong AJ, Cavallo A, Holman GH, Goldman AS. DiGeorge syndrome: long-term survival complicated with Graves disease. J Pediatr 1985;106:619-20.
26. Kawamura T, Nomura I, Hanafusa M, Fujikawa R, Okubo M, Egusa G, et al. DiGeorge syndrome with Graves disease: a case report. Endocr J 2000;47:91-5.